Atlas Trials

Characterizing the Cross-sectional Approach to Ovarian Cancer: Genetic Testing of BRCA

Clinical trial NCT03229122 · COMPLETED

Trial details

NCT number
NCT03229122
Sponsor
AstraZeneca
Status
COMPLETED
Study type
OBSERVATIONAL
Ovarian Cancer
Start date
2016-12-26
Primary completion
2018-07-06
Enrollment
446

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.